Mar 27, 2017 4:32pm EDT Second Sight Medical Products, Inc. Announces Warrants Approved for Listing on Nasdaq With Trading Scheduled to Commence March 29 under Symbol “EYESW”
Mar 09, 2017 6:50am EST Second Sight Medical Products, Inc. Announces Completion of Oversubscribed Rights Offering
Mar 02, 2017 8:00am EST Second Sight Appoints David Jacques as Vice President of Research and Development
Mar 01, 2017 4:30pm EST Second Sight to Discuss Fourth Quarter and Year-End 2016 Financial Results on March 9, 2017 Conference Call
Feb 21, 2017 8:00am EST Second Sight Announces Professor Stanislao Rizzo Has Completed His 30th Implant of the Argus II Retinal Prosthesis
Feb 06, 2017 7:13am EST Second Sight Medical Products, Inc. Announces Record Date, Subscription Pricing, Expiration Date for Rights Offering and Effectiveness of Its Registration Statement